Purchase Order HHSN261201800252P

Novogene Corp Inc., a minority-owned small business, has been awarded a firm fixed price purchase order contract valued at $24,350 by the Department of Health and Human Services' National Institutes of Health National Cancer Institute. The contract is for laboratory testing services to support genomic sequencing and bioinformatics research efforts. Specifically, Novogene will provide DNA/RNA sample sequencing and data analysis services leveraging Illumina and PacBio platforms, including whole...

<p>The National Cancer Institute awarded a purchase order to Novogene Corporation Inc. for $24,750.00 in testing services on July 27, 2020, with completion targeted for February 22, 2021. Work is performed in Chula Vista, California. Novogene is a minority-owned small business specializing in genomic sequencing and bioinformatics services. The order is firm fixed price with no set-aside category applied.</p>

<p>The National Cancer Institute awarded a purchase order to Novogene Corporation Inc. for $11,045.65 on August 7, 2020 for laboratory testing services. The order is firm fixed price with no set-aside category. Work is performed in Chula Vista, California, with an ultimate completion date of September 30, 2020. Novogene is a minority-owned small business specializing in genomic sequencing and bioinformatics services.</p>

The National Cancer Institute awarded a purchase order to Novogene Corporation Inc. for $117,038.40 on September 22, 2017, to provide laboratory services analyzing fresh-frozen tissue samples from a lung cancer study conducted in Xuanwei, China. The order is firm fixed price with no set-aside designation. Work is performed in China and concludes March 31, 2018. Novogene is a minority-owned small business based in Sacramento, California, specializing in genomic sequencing and bioinformatics...

Novogene Corp Inc., a minority-owned small business, has been awarded a firm fixed price purchase order totaling $24,864 by the National Cancer Institute, a component of the Department of Health and Human Services' National Institutes of Health. The contract calls for Novogene to provide laboratory testing services in Bethesda, Maryland, in support of the agency's biomedical research efforts. As a previous provider of genomic sequencing and bioinformatics services under over 100 federal...

<p>The National Institute of Child Health and Human Development awarded a purchase order to Novogene Corporation Inc. for $13,982.00 on August 23, 2019, for RNA sequencing services. Performance is located in Bethesda, Maryland, with completion by February 28, 2020. The order is firm fixed price with no set-aside designation. Novogene is a minority-owned small business providing genomic sequencing and bioinformatics analysis.</p>

This is a firm fixed-price purchase order awarded by the Midwest Area civilian agency to Novogene Corp Inc., a minority-owned small business, for DNA sequencing services via the Illumina NovaSeq S4 platform. The $5,964 contract has a completion date of December 31, 2019 and does not utilize a set-aside designation. Novogene is a provider of next-generation sequencing and bioinformatics services, supporting various federal agencies with projects spanning biomedical, agricultural, environmental,...

The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $24,577.00 firm fixed-price purchase order to Novogene Corp Inc., a minority-owned small business, for DNA and RNA sequencing services. This contract is set aside for small businesses. Novogene is a provider of next-generation sequencing technologies that has delivered services to support various federal agencies' biomedical, agricultural, environmental, and basic...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $22,646 purchase order to Illumina, Inc. for service agreement on a NovaSeq 6000 sequencer. The firm fixed price contract runs from December 1, 2023 through January 17, 2024 and will be performed in Rockville, Maryland. This purchase order provides sequencing services utilizing Illumina's NovaSeq 6000 platform to support the National Cancer Institute's cancer research efforts. No major...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $219,720.00 firm fixed price purchase order to Novogene Corp Inc., a minority-owned small business, to conduct RNA sequencing and bioinformatics analysis. The work supports research into identifying biomarker signatures of radiation exposure and organ-specific radiation injury using samples from a non-human primate model and human organ-on-a-chip system. The contract requires a...